This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key building block in the production of drugs targeting neurological disorders, including those related to neurotransmitter regulation. Its structure, featuring a bromophenyl group and a tert-butoxycarbonyl-protected amino moiety, makes it valuable for creating chiral molecules with specific biological activities. Additionally, it is employed in peptide chemistry for the introduction of modified amino acids into peptide chains, enhancing the stability and efficacy of peptide-based therapeutics. Its applications also extend to medicinal chemistry research, where it is used to explore structure-activity relationships in drug design.